Methods for assessing the potential of prebiotics and probiotics

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 2, Issue 6, 1999, Pages 481-484

  Rycroft, Catherine E ^a   Fooks, Laura J ^a   Gibson, Glenn R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE; PROBIOTIC AGENT;

ANIMAL; BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; MICROBIOLOGY; NUTRITIONAL VALUE; REVIEW;

ANIMALS; BACTERIA; HUMANS; INTESTINES; NUTRITIVE VALUE; OLIGOSACCHARIDES; PROBIOTICS;

EID: 0033217511     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199911000-00008     Document Type: Article

References (30)

1. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412.
2. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-378.
3. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998; 80:8209-8212.
4. Leatherhead Food RA. Functional foods and drinks in Japan. 1998; Japanscan Ltd. This study gives a very comprehensive review of functional food products, including prebiotics.
5. Yazawa K, Imai K, Tamura Z. Oligosaccharides and polysaccharides specifically utilisable by bifidobacteria. Chem Pharm Bull 1978; 26:3306-3311.
6. Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. Effects of soybean oligosaccharides on human faecal flora. Microb Ecol Health Dis 1990; 3:293-303.
7. Djouzi Z, Andrieux C, Pelenc V, Somarriba S, Popot F, Paul F, et al. Degradation and fermentation of 2-gluco-oligosaccharides by bacterial strains from human colon: in vitro and in vivo studies in gnotobiotic rats. J Appl Bacteriol 1995; 79:117-127.
8. Kullen MJ, Khil J, Busta FF, Gallaher DD, Brady LJ. Carbohydrate source and bifidobacteria influence the growth of Clostridium perfringens in vivo and in vitro. Nutr Res 1998; 18:1889-1897. This study shows competitive interactions between selected gut isolates.
9. Wang X, Gibson GR. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 1993; 75:373-380.
10. Stanbury PF, Whitaker A. Principles of fermentation technology. Oxford: Pergamon Press; 1987.
11. Gibson GR, Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol Lett 1994; 118:121-128.
12. Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 1992; 34:299-311.
13. Gibson GR, Wang X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 1994; 77:412-420.
14. Molly K, Vande Woestyne M, Verstraete W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotech 1993; 39:254-258.
15. Campbell JM, Fahey GC, Wolf BW. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J Nutr 1997; 127:130-136.
16. Valette P, Pelenc V, Djouzi Z, Andrieux C, Paul F, Monsan P, Szylit O. Bioavailability of new synthesised gluco-oligosaccharides in the intestinal tract of gnotobiotic rats. J Sci Food Agri 1993; 62:121-127.
17. Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 1993; 74:667-674.
18. Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fructo-oligosaccharides on intestinal flora and human health. Bifid Microflora 1986; 5:37-50.
19. Williams CH, Witherly SA, Buddington RK. Influence of dietary neosugar on selected bacterial groups of the human faecal microbiota. Microb Ecol Health Dis 1994; 7:91-97.
20. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and insulin. Gastroenterol 1995; 108:975-982.
21. Buddington RK, Williams CH, Chen S, Witherly SA. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 1996; 63:709-716.
22. Kleessen B, Sykura B, Zunft H-J, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65:1397-1402.
23. Ito M, Deguchi Y, Miyamori A, Matsumoto K, Kikuchi H, Matsumoto K, et al. Effects of administration of galacto-oligosaccharides on the human fecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 1990; 3:285-292.
24. Bouhnik Y, Flourie B, D'Agay-Abensour L, Pochart P, Gramet G, Durand M, Rambaud JC. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J Nutr 1997; 127:444-448.
25. O'Sullivan DJ. Methods for analysis of the intestinal microflora. In: Probiotics: a critical review. Tannock Wymondham; Horizon Scientific Press; 1999. pp. 23-44. This study describes molecular methodologies applicable to probiotics.
26. Wilson K, Blitchington RB. Human colonie bacteria studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 1996; 62:2273-2278.
27. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MHF, Welling GW. Quantitative fluorescence in situ hybridisation of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995; 61:3069-3075.
28. Tamime AY, Marshall VME, Robinson RK. Microbiological and technological aspects of milks fermented by bifidobacteria. J Dairy Res 1995; 62:151-187.
29. Welling GW, Elfferich P, Raangs GC, Wildeboer-Veloo ACM, Jansen GJ, Degener J. 16S ribosomal RNA-targeted oligonucleotide probes for monitoring of intestinal bacteria. Scand J Gastroenterol 1997; 32:17-19.
30. Sambrook J, Fritsch EF, Maniatis T, Molecular cloning: a laboratory manual, 2nd ed. New York: Cold Spring Harbor Laboratory; 1989.